PharmaBoardroom

Accumulating Barriers to Care: Double Jeopardy for US Patients

Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for…

Veronique Walsh – General Manager, Bristol Myers Squibb…

Veronique Walsh, General Manager of Bristol Myers Squibb (BMS) – Benelux, explains her ambition to build a new company culture following the…

European Pharma Mid-Caps’ US Strategies: Complexity, Scale,…

Three US country managers for European pharma mid-caps explain the challenges in setting up an American affiliate, as well as how best to capitalise…

Constanza Losada – President & CEO, Pfizer Mexico

Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking on leadership for such an…

France & Germany: A New European Approach to Health Crises

Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would ensure greater European access to…

Gerard Anderson – Professor, Johns Hopkins University…

Dr Gerard Anderson of Johns Hopkins University Bloomberg School of Public Health critiques the US response to the COVID-19 pandemic, before explaining…

Jorge Alderete – President, ALK Americas & SVP…

Jorge Alderete, president of ALK Americas, outlines the Danish mid-cap’s strategy in the challenging US market, including innovative market access…

Mirela Iordan – Country Manager, Pfizer Romania

Mirela Iordan country manager of Pfizer Romania reveals some of her milestones, including integrating new acquisitions and setting up the first…

Hot Topics in US Healthcare & Pharma

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…